VRX

Valeant Pharmaceuticals Intl

10 superinvestors own VRX

Based on latest 13F filings — data is 45–90 days delayed

Investor	Fund	Weight	Shares	Value	Quarter	Activity
Ruane Cunniff	Sequoia Fund	6.95%	10,788,269	$564.1M	2010Q2	New
Bill Ackman	Pershing Square Capital Management	4.45%	18,114,432	$263.0M	2016Q4	Reduced
Bill Miller	Miller Value Partners	4.34%	4,999,064	$116.2M	2018Q2	Reduced
ValueAct Capital	ValueAct Capital	4.28%	13,241,300	$169.9M	2008Q1	Held
Viking Global Investors	Viking Global Investors	2.99%	7,793,397	$792.2M	2015Q4	Added
Francis Chou	Chou Associates	2.66%	226,377	$11.8M	2011Q2	New
Francois Rochon	Giverny Capital	2.58%	127,735	$13.0M	2015Q4	Added
Christopher Davis	Davis Selected Advisers	0.19%	3,917,812	$43.2M	2017Q1	Reduced
First Eagle Investment Management	First Eagle Investment Management	0.02%	551,300	$7.9M	2017Q3	Held
Kenneth Fisher	Fisher Asset Management	0.00%	1,833	$327K	2015Q3	Held

Open-market purchases (P) and sales (S) from SEC Form 4 filings · last 12 months

No open-market insider trades in the last 12 months.

Form 4 filings for option exercises and other transaction types are excluded.

STOCK Act disclosures · last 12 months

Congressional trade data coming soon.

We are sourcing STOCK Act disclosures and will display them here shortly.

What Is SEC Form 4?

Understand the insider trade filings behind VRX activity.

What Is a 13F Filing?

How superinvestors disclose their quarterly holdings.

Insider Cluster Buying

Why multiple insiders buying together is a strong signal.

Superinvestor Consensus

The most widely held stocks across all tracked institutions.